Matthias Bartenstein
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Chronic Myeloid Leukemia Treatments, Histone Deacetylase Inhibitors Research, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → Hypomethylation of Noncoding DNA Regions and Overexpression of the Long Noncoding RNA, AFAP1-AS1, in Barrett's Esophagus and Esophageal Adenocarcinoma(2013)232 cited
- → IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells(2015)183 cited
- → Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts(2019)163 cited
- → The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes(2017)96 cited
- → Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells(2018)93 cited
- → North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies(2018)90 cited
- → Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model(2011)76 cited
- → ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts(2015)73 cited
- → Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.(2016)69 cited
- → Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation(2017)69 cited